1. 1061PMolecular screening in advanced cancer patients with head and neck cancers: A retrospective analysis of the MOSCATO-01 trial. (23rd October 2018) Authors: Houessinon, A; Verlingue, L; Hollebecque, A; Even, C; Lacroix, L; Postel-Vinay, S; Varga, A; El Dakdouki, Y; Balheda, R; Michot, J-M; Gazzah, A; Marabelle, A; Michiels, S; Rouleau, E; Breuskin, I; de Baere, T; Angevin, E; Scoazec, J-Y; Soria, J-C; Massard, C Journal: Annals of oncology Issue: Volume 29(2018)Supplement 8 Page Start: Record Type: Journal Article View Content: Available online (eLD content is only available in our Reading Rooms) ↗
2. 109TiPAcSé immunotherapy trials: Anti-PD-1 therapy for adult patients with selected rare cancer types. (17th December 2018) Authors: Marabelle, A; Chevret, S; Janot, F; Escudier, B; Pouessel, D; Tournigand, C; Hoang-Xuan, K; Mortier, L; Rousseau, B J-C; Schlumberger, M J; Ray-Coquard, I L; Blay, J-Y; Niccoli, P; Jaccard, A; Couch, D; Hoog-Labouret, N; Pauporte, I; Massard, C Journal: Annals of oncology Issue: Volume 29(2018)Supplement 10 Page Start: Record Type: Journal Article View Content: Available online (eLD content is only available in our Reading Rooms) ↗
3. 113P A phase I study of an anti-IDO1 inhibitor (LY3381916) as monotherapy and in combination with an anti-PD-L1 antibody (LY3300054) in patients with advanced cancer. (15th December 2019) Authors: Kotecki, N; O'Neil, B; Jalal, S; Massard, C; Wallin, J; Szpurka, A; Wang, D; Galvao, V Regnier; Xia, M S; Crowe, K; Geeganage, S; Doman, T; Gandhi, L; Xu, X; Bendell, J Journal: Annals of oncology Issue: Volume 30(2019)Supplement 11 Page Start: Record Type: Journal Article View Content: Available online (eLD content is only available in our Reading Rooms) ↗
4. 1141PDAssociation between immune-related adverse events and efficacy in patients treated with anti-PD-(L)1. (23rd October 2018) Authors: Kfoury, M; Voisin, A-L; Najean, M; Champiat, S; Laghouati, S; Michot, J-M; Robert, C; Mateus, C; Albiges, L; Besse, B; Massard, C; Texier, M; Lambotte, O; Marabelle, A Journal: Annals of oncology Issue: Volume 29(2018)Supplement 8 Page Start: Record Type: Journal Article View Content: Available online (eLD content is only available in our Reading Rooms) ↗
5. 1206PIncidence of immune related adverse events in patients 70 years old treated with anti-PD-(L)1 therapy. (23rd October 2018) Authors: Baldini, C; Martin-Romano, P; Voisin, A-L; Danlos, F X; Champiat, S; Laghouati, S; Kfouri, M; Vincent, H; Nagera, C; Postel-Vinay, S; Varga, A; Ribrag, V; Besse, B; Hollebecque, A; Lambotte, O; Michot, J-M; Soria, J-C; Massard, C; Marabelle, A Journal: Annals of oncology Issue: Volume 29(2018)Supplement 8 Page Start: Record Type: Journal Article View Content: Available online (eLD content is only available in our Reading Rooms) ↗
6. 149OOutcome and mutational landscape of patients with PIK3CA-mutated metastatic breast cancer (mBC). (13th May 2019) Authors: Mosele, M F; Lusque, A; Tran Dien, A; Droin, N; Le Tourneau, C; Lacroix, L; Bieche, I; Massard, C; Bertucci, F; André, F Journal: Annals of oncology Issue: Volume 30(2019)Supplement 3 Page Start: Record Type: Journal Article View Content: Available online (eLD content is only available in our Reading Rooms) ↗
7. 1843PMolecular alterations and matched treatment in older patients: Results from the MOSCATO 01 trial. (23rd October 2018) Authors: Vuagnat, P; Baldini, C; Verlingue, L; Martin Romano, P; Varga, A; Hollebecque, A; Postel-Vinay, S; Gazzah, A; Bahleda, R; Marabelle, A; Ribrag, V; Champiat, S; Michot, J-M; Soria, J-C; Massard, C Journal: Annals of oncology Issue: Volume 29(2018)Supplement 8 Page Start: Record Type: Journal Article View Content: Available online (eLD content is only available in our Reading Rooms) ↗
8. 1885PPrecision medicine for patients with rare cancers: An effective strategy within the prospective MOSCATO trial. (23rd October 2018) Authors: Abdelshafy, M; El Dakdouki, Y; Verlingue, L; Hollebecque, A; Lacroix, L; Postel-Vinay, S; Varga, A; Balheda, R; Michot, J-M; Marabelle, A; Rouleau, E; Solary, E; de Baere, T; Angevin, E; Ribrag, V; Michiels, S; André, F; Scoazec, J-Y; Soria, J-C; Massard, C Journal: Annals of oncology Issue: Volume 29(2018)Supplement 8 Page Start: Record Type: Journal Article View Content: Available online (eLD content is only available in our Reading Rooms) ↗
9. 26PA combination of resistance mechanisms is frequent in non-small cell lung cancer (NSCLC) that progressed to EGFR tyrosine kinase inhibitors (TKIs). (7th November 2019) Authors: Enrico, D H; Lacroix, L; Rouleau, E; Scoazec, J-Y; Loriot, Y; Tselikas, L; Jovelet, C; Planchard, D; Gazzah, A; Mezquita, L; Ngo, M; Michiels, S; Maillard, A; Massard, C; Facchinetti, F; Soria, J-C; André, F; Vassal, G; Friboulet, L; Besse, B Journal: Annals of oncology Issue: Volume 30(2019)Supplement 7 Page Start: Record Type: Journal Article View Content: Available online (eLD content is only available in our Reading Rooms) ↗
10. 296PApplicability of the lung immune prognostic index (LIPI) to metastatic triple negative breast cancer (mTNBC) patients treated with immune checkpoint targeted monoclonal antibodies (ICT mAbs). (23rd October 2018) Authors: Vozy, A; Simonaggio, A; Auclin, E; Mezquita, L; Baldini, C; Martin-Romano, P; Pistilli, B; Gazzah, A; Bahleda, R; Ribrag, V; Postel-Vinay, S; Champiat, S; Soria, J-C; André, F; Massard, C; Besse, B; Delaloge, S; Varga, A Journal: Annals of oncology Issue: Volume 29(2018)Supplement 8 Page Start: Record Type: Journal Article View Content: Available online (eLD content is only available in our Reading Rooms) ↗